Johnson & Johnson news, latest stories & analysis

Find today's trending Johnson & Johnson news & headlines

BofA reveals stocks with a history of steady returns amid market volatility
BofA reveals stocks with a history of steady returns amid market volatility
  • Bank of America is bullish on Johnson & Johnson and Clorox stocks.
  • Analysts at the firm expect JNJ and CLX to do well amidst market downturn.
  • A brief overview of what each of the two have in store for investors in 2025.
March 24, 2025
Top 3 recession-proof stocks to buy as US monthly jobs data disappoints again
Top 3 recession-proof stocks to buy as US monthly jobs data disappoints again
September 8, 2024
Forget Eli Lilly: Why Johnson & Johnson could be the next trillion-dollar pharma stock
Forget Eli Lilly: Why Johnson & Johnson could be the next trillion-dollar pharma stock
August 22, 2024

Trending news

More breaking stories

Top 10 pharmaceutical companies in 2024: S&P Global’s latest ratings and rankings
Top 10 pharmaceutical companies in 2024: S&P Global’s latest ratings and rankings August 19, 2024
High-emission industries lag in R&D investment: Why it matters
High-emission industries lag in R&D investment: Why it matters August 4, 2024
Wells Fargo faces lawsuit over alleged health plan mismanagement and inflated prescription costs
Wells Fargo faces lawsuit over alleged health plan mismanagement and inflated prescription costs July 30, 2024
Johnson & Johnson proposes $6.475 billion settlement in talc lawsuits
Johnson & Johnson proposes $6.475 billion settlement in talc lawsuits May 1, 2024
Earnings turnaround for Johnson & Johnson with Q1 2024 financial results
Earnings turnaround for Johnson & Johnson with Q1 2024 financial results April 16, 2024
Johnson & Johnson to buy Shockwave Medical for $12.5 billion
Johnson & Johnson to buy Shockwave Medical for $12.5 billion April 5, 2024
Top four dividend stocks to watch now in March 2024
Top four dividend stocks to watch now in March 2024 March 6, 2024
J&J Q4 earnings narrowly top expectations
J&J Q4 earnings narrowly top expectations January 23, 2024
Ambrx Biopharma stock doubles on JNJ deal
Ambrx Biopharma stock doubles on JNJ deal January 8, 2024
JNJ ‘was never dependent on COVID vaccine’ for success: CFO Wolk
JNJ ‘was never dependent on COVID vaccine’ for success: CFO Wolk October 17, 2023
Johnson & Johnson stock price forecast: RBC analyst sees a 15% upside
Johnson & Johnson stock price forecast: RBC analyst sees a 15% upside October 5, 2023
J&J raises full-year outlook: ‘we’re in a very strong position’
J&J raises full-year outlook: ‘we’re in a very strong position’ July 20, 2023
Johnson & Johnson files lawsuit against Biden administration
Johnson & Johnson files lawsuit against Biden administration July 18, 2023
Jim Cramer says be ‘very careful’ on J&J stock: here’s why
Jim Cramer says be ‘very careful’ on J&J stock: here’s why July 10, 2023

Other topics

Glencore news
Health & pharma news
IPO news
Indices news
Industri news
JetBlue Airways news
Kamala Harris news
Keir Starmer news
Leisure & entertainment news
Li Auto news
Lucid Motors news
Manufacturing news